tiprankstipranks
Advertisement
Advertisement

HK:1011 Stock Latest News

China NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
Company AnnouncementsChina NT Pharma Discloses Auditor’s Retirement and Plans to Appoint Successor
2d ago
1011
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
PremiumCompany Announcements
China NT Pharma Shareholders Reject Auditor but Approve Capital Mandates at AGM
10d ago
1011
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
PremiumCompany Announcements
China NT Pharma Explores Sale of Overseas Unit to Ease Liquidity Strain
16d ago
1011
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
PremiumCompany Announcements
China NT Pharma Discloses Governance Dispute Behind Director’s Resignation
25d ago
1011
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
PremiumCompany Announcements
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
30d ago
1011
China NT Pharma details board and committee structure
PremiumCompany AnnouncementsChina NT Pharma details board and committee structure
1M ago
1011
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
Premium
Company Announcements
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
1M ago
1011
China NT Pharma Reshapes Audit Oversight with New Independent Director
Premium
Company Announcements
China NT Pharma Reshapes Audit Oversight with New Independent Director
1M ago
1011
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
PremiumCompany Announcements
China NT Pharma Advances AI Health Pivot as It Negotiates Debt Restructuring
1M ago
1011
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
PremiumCompany Announcements
China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
1M ago
1011
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
PremiumCompany Announcements
China NT Pharma Names Major Shareholder Lou Yongbin as Non-Executive Director to Support AI Healthcare Pivot
2M ago
1011
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
PremiumCompany Announcements
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
2M ago
1011
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
PremiumCompany AnnouncementsChina NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
3M ago
1011
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
Premium
Company Announcements
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
3M ago
1011
China NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
China NT Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
3M ago
1011
China NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
PremiumCompany Announcements
China NT Pharma Flags Sharply Narrower 2025 Loss Driven by Fair Value Gains
4M ago
1011
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
PremiumCompany Announcements
China NT Pharma Drops Convertible Bond Plan, Trading to Resume
4M ago
1011
China NT Pharma Halts Trading Pending Details on Convertible Bond Issue
PremiumCompany Announcements
China NT Pharma Halts Trading Pending Details on Convertible Bond Issue
4M ago
1011
China NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
PremiumCompany Announcements
China NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
4M ago
1011
China NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
PremiumCompany AnnouncementsChina NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
5M ago
1011
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
Premium
Company Announcements
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
5M ago
1011
China NT Pharma Calls EGM to Approve Major Acquisition and Share Issuance
Premium
Company Announcements
China NT Pharma Calls EGM to Approve Major Acquisition and Share Issuance
6M ago
1011

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >